The investigational product was designed based on similar vectors made for CLN7 disease and giant axonal neuropathy13 and includes codon-optimized human AP4M1 driven from the JeT promoter and encapsulated into scAAV9 (AAV9-AP4M1; Extended Data Fig. 1)14. The gene discussed is AP4M1; the disease is CLN7 disease.